MD Pharmaceuticals Pte Ltd Presents BioCell Collagen® at the 35th Annual Scientific Meeting (ASM) of the Singapore Orthopaedic Association


Latest Published Clinical Data Demonstrates BioCell Collagen is an Effective Solution for Improving Joint Comfort, Mobility and Quality of Life

Newport Beach, California – October 15, 2012 - The sponsored symposium titled “BioCell Collagen: A novel holistic dietary solution to joint and connective tissue health” was held at the Four Seasons Hotel, Singapore on October 12, 2012 where Joosang Park, PhD, MBA presented latest scientific data on BioCell Collagen to leading doctors in the field of orthopedics. This year’s ASM was combined with the 6th annual ASEAN Arthroplasty Association Meeting, making the event one of the largest gatherings of orthopedic professionals in Singapore.


“Glucosamine and chondroitin formulations have been used as the standard of care in joint health for more than two decades with limited success. The big question in the mind of health care practitioners today is what’s next in joint health. I believe BioCell Collagen offers significant advantages with its advanced patented composition which mirrors human articular cartilage and provides bioavailable collagen type II and hyaluronic acid for the comprehensive maintenance of healthy joint function”, said Melvin Wong, President of MD Pharmaceuticals. Within the last year, MD Pharmaceuticals has introduced BioCell Collagen in Singapore as a prescription only product made available through general practitioners and orthopedic surgeons. 


“We are pleased to have partnered with MD Pharmaceuticals to bring BioCell Collagen to orthopedic surgeons and general practitioners in Singapore at this highly specialized and targeted scientific meeting” said Suhail Ishaq, president.  “We have always believed that addressing joint health requires a comprehensive approach, one that not only targets cartilage, but the related tendons, ligaments, and synovial fluid.  Orthopedic doctors are prescribing MD Pharmaceuticals BioCell Collagen as a complement to traditional therapies and for post-surgical joint support.”


 About BioCell Collagen®:


BioCell Collagen is a breakthrough patented ingredient that provides a bioavailable matrix of collagen and hyaluronic acid. BioCell Collagen has been clinically proven to promote active joints, youthful looking skin, and healthy connective tissues.  Unlike other collagen and hyaluronic acid ingredients on the market, BioCell Collagen contains a patented composition of naturally occurring hydrolyzed collagen type II, chondroitin sulfate, and hyaluronic acid in a matrix form. This makes it much easier for the body to absorb and deliver it to key areas where it’s most needed as we age including our joints, skin, tendons, ligaments and blood vessels.  For more information on BioCell Collagen ®, please visit


About MD Pharmaceuticals Pte Ltd


MD Pharmaceuticals Pte Ltd was established in January 1995 to provide professional pharmaceutical and healthcare marketing, sales and distribution services in Singapore and some ASEAN countries. The company started with a few products but today has a strong portfolio of over 50 products in orthopaedics, gastroenterology, respiratory diseases, arthritis/pain, infectious diseases, paediatrics, urology, and obstetrics and gynaecology. For more information please visit


About BioCell Technology, LLC


BioCell Technology, LLC, founded in 1997, is in the business of researching, developing, branding, and distributing novel dietary ingredients which are supported by science to improve quality of life. BioCell Technology's branded ingredients are available under licensing to marketers and manufacturers of finished products. Popular ingredient brands include BioCell Collagen II for skin/joint health and i-Sabi for immune system support.